News & Updates

Asian experts issue consensus statement on use of Ginkgo biloba in mild cognitive impairment

06 Feb 2021 by

The Asian Clinical Expert Group on Neurocognitive Disorders (ASCEND) has issued a consensus statement, suggesting it is clinically appropriate to incorporate Ginkgo biloba extract as part of the multidomain intervention for mild cognitive impairment (MCI). [CNS Neurosci Ther 2021;27:149-162]

Asian experts issue consensus statement on use of Ginkgo biloba in mild cognitive impairment

06 Feb 2021

SUMO1-derived peptide inhibitor a potential treatment for Parkinson’s disease

06 Feb 2021 by

Researchers from the Chinese University of Hong Kong (CUHK) have developed a novel peptide inhibitor that can reduce the accumulation of α-synuclein amyloid fibrils, slowing down the progress of deterioration in patients with Parkinson’s disease and other types of neurodegenerative diseases.

SUMO1-derived peptide inhibitor a potential treatment for Parkinson’s disease

06 Feb 2021

Staying active protects against anxiety, apathy in Parkinson’s disease

05 Feb 2021 by

Higher levels of physical activity may help combat anxiety and apathy among patients with early Parkinson’s disease (PD), according to a recent Singapore study.

Staying active protects against anxiety, apathy in Parkinson’s disease

05 Feb 2021

Bayer pharma applies breakthrough innovations to manage difficult-to-treat conditions

05 Feb 2021 by

Bayer reveals major transformation in its pharmaceutical business with the use of breakthrough innovations aimed at helping patients with difficult-to-treat conditions.

Bayer pharma applies breakthrough innovations to manage difficult-to-treat conditions

05 Feb 2021

Irritable bowel syndrome implicated in Parkinson’s disease

04 Feb 2021

Patients with irritable bowel syndrome may be at heightened risk of developing future Parkinson’s disease, as suggested in a study.

Irritable bowel syndrome implicated in Parkinson’s disease

04 Feb 2021

Psychosocial morbidity, HRQoL worse among people with lower back pain

04 Feb 2021

People with lower back pain (LBP) suffer from heightened psychological morbidity, leading to worse health-related quality of life (HRQoL) and loss in productivity, a recent study has found.

Psychosocial morbidity, HRQoL worse among people with lower back pain

04 Feb 2021

Cerebral palsy bears potentially increased hazard of dementia

04 Feb 2021

Adults with cerebral palsy are at higher risk of developing dementia compared with the general population, but this risk is likely driven by CP comorbidities rather than a direct effect of having the disorder, a study reports.

Cerebral palsy bears potentially increased hazard of dementia

04 Feb 2021

Sirolimus shows promise for Sturge-Weber

03 Feb 2021

Sirolimus is well-tolerated and may provide cognitive benefits for patients with the Sturge-Weber syndrome, reports a new study.

Sirolimus shows promise for Sturge-Weber

03 Feb 2021

Cerebral microbleeds predict adverse cardiac, cerebrovascular events in CAD patients

03 Feb 2021

The presence of cerebral microbleeds is associated with major adverse cardiac and cerebrovascular events in patients with coronary artery disease (CAD) on antithrombotic treatment, a study has found.

Cerebral microbleeds predict adverse cardiac, cerebrovascular events in CAD patients

03 Feb 2021

King’s staging provides convenient system for amyotrophic lateral sclerosis

03 Feb 2021 by

The King’s College staging for amyotrophic lateral sclerosis (ALS) features a large degree of congruity, making it easy to remember and suitable for modeling the trajectory of limb- and bulbar-onset ALS in Singapore, suggests a new study.

King’s staging provides convenient system for amyotrophic lateral sclerosis

03 Feb 2021

News & Updates

Filter by Specialty:

Specialty:

Asian experts issue consensus statement on use of Ginkgo biloba in mild cognitive impairment

Asian experts issue consensus statement on use of Ginkgo biloba in mild cognitive impairment

SUMO1-derived peptide inhibitor a potential treatment for Parkinson’s disease

SUMO1-derived peptide inhibitor a potential treatment for Parkinson’s disease

Staying active protects against anxiety, apathy in Parkinson’s disease

Staying active protects against anxiety, apathy in Parkinson’s disease

Bayer pharma applies breakthrough innovations to manage difficult-to-treat conditions

Bayer pharma applies breakthrough innovations to manage difficult-to-treat conditions

Irritable bowel syndrome implicated in Parkinson’s disease

Irritable bowel syndrome implicated in Parkinson’s disease

Psychosocial morbidity, HRQoL worse among people with lower back pain

Psychosocial morbidity, HRQoL worse among people with lower back pain

Cerebral palsy bears potentially increased hazard of dementia

Cerebral palsy bears potentially increased hazard of dementia

Sirolimus shows promise for Sturge-Weber

Sirolimus shows promise for Sturge-Weber

Cerebral microbleeds predict adverse cardiac, cerebrovascular events in CAD patients

Cerebral microbleeds predict adverse cardiac, cerebrovascular events in CAD patients

King’s staging provides convenient system for amyotrophic lateral sclerosis

King’s staging provides convenient system for amyotrophic lateral sclerosis